LUXEMBOURG, July 3, 2025 /PRNewswire/ -- Adecoagro S.A. (NYSE: AGRO) ("Adecoagro" or the "Company"), a leading sustainable production company in South America and Tether...
ZINFI Again Named a G2 Leader in Partner Relationship Management for Summer 2025, Achieving Highest Satisfaction Rating in the Industry
PLEASANTON, Calif., July 3, 2025...
OSLO, Norway, July 3, 2025 /PRNewswire/ -- Norway-based browser developer, Opera , is breaking down language barriers for its users with the launch of...
ALTRINCHAM, England, July 3, 2025 /PRNewswire/ -- A new study is the first to examine the application of behavioural science in getting underused therapies...
VANCOUVER, BC, July 2, 2025 /PRNewswire/ -- MiniTool Software Limited has released a new version of its video conversion tool – MiniTool Video Converter 4.3. This...
KUALA LUMPUR, Malaysia, July 3, 2025 /PRNewswire/ -- Eye Level Malaysia, a leading name in supplemental education, is thrilled to announce its special Mid-Year Promo,...
INDIANAPOLIS and DENVER, July 2, 2025 /PRNewswire/ -- After 4 years in development, Lore Link is now publicly available as an online management tool...
Austin, TX, July 02, 2025 (GLOBE NEWSWIRE) -- TradeSpartus, a leading innovator in real-time market data analysis, proudly announces the release of its latest trading algorithm, designed to deliver immediate buy and sell signals during trend reversals. This cutting-edge tool is compatible with a wide range of markets, including stocks, futures, forex, options, and ETFs, and integrates seamlessly with major global exchanges.
Discover why the Matsato Knife is gaining global recognition in 2025. Explore expert insights, key features, and authentic user experiences behind this precision-crafted Japanese blade.
Discover why the Matsato Knife is gaining global recognition in 2025. Explore expert insights, key features, and authentic user experiences behind this precision-crafted Japanese blade.
SAN DIEGO, July 2, 2025 /PRNewswire/ -- A new prospective study published in BMC Cancer demonstrates that a novel blood-based multi-omics test, SeekInClarity, can accurately...
TALLAHASSEE, Fla., July 2, 2025 /PRNewswire/ -- Florida has enacted new legislation with a transformative approach to tackling the pollution associated with septic tanks....
SHEFFIELD, England, July 2, 2025 /PRNewswire/ -- The University of Sheffield Students' Union (SU), long recognised as the UK's top student unions, is launching a...
Munich, Germany – July 2, 2025 -- Ebenbuild, a company developing personalized, AI-enabled digital twins of lungs to support clinical decisions and digital clinical trials, today announced that it has received Euro 2.3 million funding under the European Innovation Council (EIC) Accelerator program to advance its digital twin platform technology. In addition, the EIC fund will invest up to €10 million in future equity financing rounds raised by Ebenbuild. The funding will support the market launch of Twinhale, the first in silico trial software built for pulmonary drug delivery. The investment also underpins Ebenbuild’s broader platform strategy to transform respiratory care through personalized lung simulation – from drug development to mechanical ventilation optimization in critical care.
GURUGRAM, India, July 2, 2025 /PRNewswire/ -- In today's digital world, protecting premium video content is more critical than ever. While streaming has unlocked...